Article metrics

Original research
Safety profile of anifrolumab in patients with active SLE: an integrated analysis of phase II and III trials

 

Online download statistics by month:

Online download statistics by month: February 2021 to October 2024

AbstractFullPdf
Feb 2021638638166
Mar 2021422420140
Apr 202131330486
May 2021410405149
Jun 2021369364118
Jul 202134133577
Aug 2021451447153
Sep 2021322314114
Oct 2021328325102
Nov 2021347342122
Dec 202127326779
Jan 202223223680
Feb 202223022385
Mar 202233233189
Apr 202227426476
May 202229228693
Jun 202223122379
Jul 202215415338
Aug 202220920173
Sep 202221120075
Oct 202216916250
Nov 202220019272
Dec 202211010151
Jan 202316314953
Feb 202326225064
Mar 202320819557
Apr 2023262258101
May 202318718264
Jun 202320720894
Jul 202317116553
Aug 202318417236
Sep 202318317336
Oct 202317016445
Nov 202316815439
Dec 202315615137
Jan 202418212647
Feb 202423211749
Mar 2024174169160
Apr 202425424774
May 202423321173
Jun 202414212334
Jul 202417115350
Aug 2024868250
Sep 20241059853
Oct 202415814551
Total10916104253487